Published in Gut on December 13, 2007
Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial. Psychosomatics (2010) 1.60
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev (2009) 1.24
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun (2010) 0.97
Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci (2009) 0.92
Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepat Rep (2010) 0.92
Peripheral inflammation is associated with remote global gene expression changes in the brain. J Neuroinflammation (2014) 0.91
Depressogenic effects of medications: a review. Dialogues Clin Neurosci (2011) 0.89
Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.87
Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? J Consult Clin Psychol (2012) 0.87
Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. Eur J Clin Pharmacol (2010) 0.86
Risk factors for the development of depression in patients with hepatitis C taking interferon-α. Neuropsychiatr Dis Treat (2011) 0.86
Treatment decisions and contemporary versus pending treatments for hepatitis C. Nat Rev Gastroenterol Hepatol (2013) 0.84
Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci (2011) 0.83
Hepatitis C comorbidities affecting the course and response to therapy. World J Gastroenterol (2009) 0.82
Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials. BMJ Open (2011) 0.81
Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices. Gen Hosp Psychiatry (2009) 0.79
Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection. Clin Liver Dis (Hoboken) (2012) 0.78
Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C. Open Infect Dis J (2010) 0.77
Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy? Gut (2009) 0.77
Management of Psychiatric Disease in Hepatitis C Treatment Candidates. Curr Hepat Rep (2010) 0.77
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1. Sci Rep (2016) 0.76
Bupropion for interferon-alpha-induced depression in patients with hepatitis C viral infection: an open-label study. Psychiatry Investig (2015) 0.76
Psychiatric clearance for patients started on interferon-alpha-based therapies. Am J Psychiatry (2013) 0.75
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem. Curr Neuropharmacol (2016) 0.75
Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysis. Can J Gastroenterol (2013) 0.75
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93
A novel pathway of DNA end-to-end joining. Cell (1990) 2.61
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Circular dichroism of ribonucleoprotein complexes from rat liver nuclei. Biochem Biophys Res Commun (1977) 1.69
Expression of the Bacillus subtilis sacB gene leads to sucrose sensitivity in the gram-positive bacterium Corynebacterium glutamicum but not in Streptomyces lividans. J Bacteriol (1992) 1.68
Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis. Ann Neurol (1998) 1.60
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol (1997) 1.48
Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46
Studies on the orientation of brush-border membrane vesicles. Biochem J (1978) 1.46
Accumulation of sulfoquinovosyl-1-O-dihydroxyacetone in a sulfolipid-deficient mutant of Rhodobacter sphaeroides inactivated in sqdC. Arch Biochem Biophys (1997) 1.44
[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41
Comparison of anal sonography with conventional needle electromyography in the evaluation of anal sphincter defects. Am J Gastroenterol (1996) 1.40
LAV/HTLV-III in 20-week fetus. Lancet (1985) 1.40
Pentamidine and hypoglycaemia. Lancet (1989) 1.39
[Disseminated lymphangioleiomyomatosis]. Geburtshilfe Frauenheilkd (1992) 1.38
Spectroscopic evidence for the interaction of phalloidin with actin. FEBS Lett (1975) 1.28
Multicenter quality assessment of PCR methods for detection of enteroviruses. J Clin Microbiol (1999) 1.23
Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics (2000) 1.16
Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.15
Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol (2001) 1.15
Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14
Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther (2002) 1.13
Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Arch (1999) 1.12
Isolation of insertion elements from gram-positive Brevibacterium, Corynebacterium and Rhodococcus strains using the Bacillus subtilis sacB gene as a positive selection marker. FEMS Microbiol Lett (1995) 1.11
Phenotypic analysis of the sensitivity of HIV-1 to inhibitors of the reverse transcriptase, protease, and integrase using a self-inactivating virus vector system. J Med Virol (2001) 1.09
Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany). Scand J Gastroenterol Suppl (1989) 1.08
Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat (2005) 1.07
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. Transplant Proc (1998) 1.05
Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci (2001) 1.04
The staphylococcal phosphoenolpyruvate-dependent phosphotransferase system. Purification and characterisation of the galactoside-specific membrane-component enzyme II. Eur J Biochem (1981) 1.04
On the effect of prostaglandins E2 and F2alpha on bronchial tonus in cats. Eur J Pharmacol (1974) 1.02
Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99
Integration of narrow-host-range vectors from Escherichia coli into the genomes of amino acid-producing corynebacteria after intergeneric conjugation. J Bacteriol (1996) 0.98
Fast-growing gastric inflammatory pseudotumor: a rare manifestation of peptic ulcer disease. Endoscopy (2002) 0.98
Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol (1992) 0.98
Cavernous transformation of the portal vein associated with common bile duct strictures: report of two cases. Gastrointest Endosc (1998) 0.98
Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc (1999) 0.97
Successful treatment of a gastric leak after bariatric surgery using endoluminal vacuum therapy. Endoscopy (2013) 0.97
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients. Eur J Med Res (2002) 0.97
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet (1999) 0.96
Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. Br J Clin Pharmacol (1985) 0.96
The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Dispos (1999) 0.96
Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta (1992) 0.95
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment. Eur J Med Res (2003) 0.94
The role of the Corynebacterium glutamicum rel gene in (p)ppGpp metabolism. Microbiology (1998) 0.94
Pancreatic autoantibodies in Crohn's disease: a family study. Gut (1997) 0.94
Identification, cloning and sequencing of the replication region of Lactococcus lactis ssp. lactis biovar. diacetylactis Bu2 citrate plasmid pSL2. FEMS Microbiol Lett (1991) 0.93
The basal ganglia in haemochromatosis. Neuroradiology (2000) 0.93
Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis (2008) 0.93
Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol (1998) 0.92
Cloning, nucleotide sequence, and overexpression of smoS, a component of a novel operon encoding an ABC transporter and polyol dehydrogenases of Rhodobacter sphaeroides Si4. J Bacteriol (1997) 0.92
Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res (2002) 0.92
Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr (1997) 0.91
mARVCF cellular localisation and binding to cadherins is influenced by the cellular context but not by alternative splicing. J Cell Sci (2001) 0.91
Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol (1992) 0.90
Structure and function of nuclear ribonucleoprotein complexes. Rev Physiol Biochem Pharmacol (1978) 0.89
Sonographic, manometric, and myographic evaluation of the anal sphincters morphology and function. Dis Colon Rectum (1993) 0.88
Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. Transplant Proc (1998) 0.88
Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Infection (2004) 0.88
Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed (2006) 0.88
Expression pattern of gastrointestinal selenoproteins--targets for selenium supplementation. Nutr Cancer (1998) 0.88
[The electron microscopic cytomorphology of gynecomastia]. Virchows Arch A Pathol Pathol Anat (1969) 0.87
Construction of L-lysine-overproducing strains of Brevibacterium lactofermentum by targeted disruption of the hom and thrB genes. Appl Microbiol Biotechnol (1996) 0.87
Low molecular weight RNAs as components of nuclear ribonucleoprotein particles containing heterogeneous nuclear RNA. Biochim Biophys Acta (1979) 0.87
Isolation and characterization of a dibenzofuran-degrading yeast: identification of oxidation and ring cleavage products. Appl Environ Microbiol (1998) 0.86
The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol (2009) 0.86
Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection (1998) 0.86
Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections. J Clin Virol (1998) 0.86
Factors affecting mass transfer limited biodegradation in saturated porous media. J Contam Hydrol (2001) 0.86
Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr (1998) 0.86
Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide. Chem Res Toxicol (1997) 0.85
Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies. J Clin Gastroenterol (1996) 0.85
[Electron-microscopic and experimental investigations of the morphology of gynaecomastia]. Verh Dtsch Ges Pathol (1968) 0.85
Growth control in mammalian cells by cell-cell contacts. Environ Health Perspect (1990) 0.84
Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr Cancer (2000) 0.84
Orf followed by erythema multiforme. J Eur Acad Dermatol Venereol (2006) 0.84
What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients? Cerebrovasc Dis (2013) 0.84
Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med (1990) 0.84
A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. J Immunol Methods (1997) 0.84
Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-gamma and IL-10. Virology (1996) 0.83
CPY* and the power of yeast genetics in the elucidation of quality control and associated protein degradation of the endoplasmic reticulum. Curr Top Microbiol Immunol (2005) 0.83
Paroxetine for the prevention of depression induced by interferon alfa. N Engl J Med (2001) 0.83
Correlation of immune defects in hemophilia with HTLV-III antibody titers. Vox Sang (1986) 0.83
[Electron microscopic and histochemical studies of the morphology and function of myoepithelial cells]. Verh Dtsch Ges Pathol (1967) 0.82
[Phlegmonous gastritis in a 44-year-old woman on immunosuppressive therapy]. Dtsch Med Wochenschr (2007) 0.82
Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatol (1994) 0.82
The effect of chronic lithium application on the mineral content of rat bone and soft tissues. Int Pharmacopsychiatry (1975) 0.82
[Coparative photometric and electron microscopic studies on isolated rat brain mitochondria and microsomes in vitro under conditions of osmotic swelling and ATP-induced contraction]. Brain Res (1968) 0.82
Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology (2001) 0.82
[Progressive scleroderma and the terminal stage of malignant hypertension]. Arch Klin Med (1968) 0.82
Thermalization of strongly coupled field theories. Phys Rev Lett (2011) 0.82
Phalloidin counteracts the inhibitory effect of actin on deoxyribonuclease I. FEBS Lett (1975) 0.81